Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:751-756
Published online before print December 16, 2002, doi: 10.1161/01.HYP.0000047878.13793.41
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/3/751    most recent
01.HYP.0000047878.13793.41v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vázquez, J.
Right arrow Articles by Raizada, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vázquez, J.
Right arrow Articles by Raizada, M. K.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Cell signalling/signal transduction
Right arrow Hypertension - basic studies

(Hypertension. 2003;41:751.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Transduction of a Functional Domain of the AT1 Receptor in Neurons by HIV-Tat PTD

Jorge Vázquez; Chengwen Sun; Jianqing Du; Lucía Fuentes; Colin Sumners; Mohan K. Raizada

From the Department of Physiology and Functional Genomics and the University of Florida, McKnight Brain Institute, Gainesville.

Correspondence to Mohan K. Raizada, PhD, Professor, Department of Physiology and Functional Genomics, PO Box 100274, University of Florida, College of Medicine, Gainesville, FL 32610. E-mail mraizada{at}phys.med.ufl.edu

Despite advances in transgenic and gene transfer technologies, in vivo structure–function studies of the angiotensin II type I receptor (AT1R) have revealed limited information on the diverse actions of angiotensin II. Our objective in the present study was to determine if protein transduction technology with the use of the HIV-Tat protein transduction domain could fill this gap. Recombinant HIV-Tat protein transduction domain fused to EGFP and to the third intracellular loop of the AT1R was expressed. Incubation of hypothalamus and brainstem neurons with this peptide indicated an efficient transport of the protein to most of the cells. This transduction was accompanied by an increase in neuronal firing rate, an effect similar to that observed with angiotensin II stimulation of the neuronal AT1R. The characteristics of the chronotropic effects of recombinant third intracellular loop and its synthetic counterpart were similar and comparable to the effects of angiotensin II on these neurons. In addition, in the presence of the protein kinase C inhibitor calphostin C, the peptide failed to increase firing rate. These observations demonstrated that transduction of neurons with the third intracellular loop of the AT1R produces chronotropic effects similar to those induced by angiotensin II. The data suggests that protein transduction technology could be useful for in vivo AT1R domain transduction.


Key Words: receptors, angiotensin II • protein kinases • transduction technology




This article has been cited by other articles:


Home page
Acta Biochim Biophys SinHome page
X. Yan, S. Walayat, Q. Shi, J. Zheng, and Y. Wang
Development of a soluble PTD-HPV18E7 fusion protein and its functional characterization in eukaryotic cells
Acta Biochim Biophys Sin, November 1, 2009; 41(11): 900 - 909.
[Abstract] [Full Text] [PDF]